Artificial intelligence and treatment decisions

Dr. Pratik Shah speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about the use of artificial intelligence (AI) to guide treatment decisions to improve outcomes in patients.

The International Myeloma Foundation (IMF) is an American non-profit organization serving patients with myeloma, a cancer of plasma cells in the bone marrow. The IMF also provides support and information for family members, caregivers of myeloma patients, physicians and nurses.

Dr. Shah gives examples of how AI can be used in the healthcare setting—which include the use of non stained images for computational staining of tumors and novel algorithms to determine dose recommendations to limit toxicity in glioblastoma patients.

Related Content